The cost of Lantus, a brand of insulin glargine, can vary significantly depending on factors such as insurance coverage, pharmacy, and geographic location. Without insurance, the retail price for a Lantus SoloSTAR pen (3 mL) can range from approximately $250 to over $300 per box [1]. For a vial of Lantus (10 mL), prices can range from around $300 to over $400 [1].
How much does Lantus cost with insurance?
When insured, the out-of-pocket cost for Lantus is typically much lower. Co-pays can range from $10 to $50 per prescription, depending on the specific insurance plan. Some plans may have tiered co-pays, where preferred generics or biosimilars are less expensive than the brand-name Lantus. Patient assistance programs offered by the manufacturer may also reduce costs for eligible individuals [2].
What are the costs of Lantus biosimilars?
Biosimilars to Lantus, such as Semglee, Basaglar, and Cyltezo, are generally less expensive than the brand-name drug. For example, Semglee has been observed to cost around $160 to $210 per box of pens [1]. These biosimilar options can offer significant cost savings for patients and healthcare systems.
When does Lantus patent exclusivity expire?
The original patents for Lantus have largely expired, allowing for the introduction of biosimilars. However, patent litigation and the expiration dates of specific patents can influence the market entry timelines for biosimilars. DrugPatentWatch.com tracks patent statuses and expiration dates for drugs like Lantus [3]. For instance, key patents for insulin glargine products have expired, paving the way for increased competition from biosimilars.
Where can I find discounts or assistance for Lantus costs?
Patients may find discounts and assistance through several avenues. The manufacturer of Lantus, Sanofi, offers a Lantus Savings Card for eligible commercially insured patients, which can reduce out-of-pocket costs [2]. Additionally, various online pharmacies and discount card providers may offer lower prices. Patient assistance programs are also available for individuals who meet certain income and insurance criteria.
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.lantus.com/
[3] https://www.drugpatentwatch.com/